Cellectis SA (CLLS)
2.975
+0.04
(+1.54%)
USD |
NASDAQ |
Jun 09, 12:55
Cellectis SG&A Expense (Quarterly) : 5.610M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DBV Technologies SA | 15.36M |
| Akari Therapeutics Plc | 2.165M |
| Amarin Corp. Plc | 19.35M |
| Grifols SA | 328.75M |
| Autolus Therapeutics Plc | 39.89M |